Objectives: To explore the prevalence of orofacial pain (OFP) among patients with vulvar vestibulitis syndrome (VVS) and to examine the relationship between signs and symptoms of OFP and clinical characteristics of women with VVS, we investigated differences in psychologic characteristics and severity of painful intercourse.
V ulvar vestibulitis syndrome (VVS), the most common type of chronic vulvovaginal pain, impairs the psychologic, physical, and reproductive health of nearly 1 in 10 women at some point in their lifetime.
1 VVS is also known as localized vulvodynia, vestibulodynia, and, in 2004, was renamed as ''provoked localized vulvodynia'' by the International Society for the Study of Vulvovaginal Disease (ISSVD). 2, 3 However, the clinical diagnosis of VVS has not changed since it was originally introduced by Friedrich, 4 and is based on self-report of severe pain upon vaginal entry and tenderness to pressure localized within the vulvar mucosa (vestibule). 5 To date, the etiology of VVS remains poorly understood, and the diagnosis is made after excluding other known gynecologic disorders in the face of persistent pain with genital contact (eg, tampon use or intercourse). 6 Although the current definition of VVS is based on a local pain conceptualization of this condition, an emerging body of evidence supports the notion of VVS as a complex pain disorder, akin to idiopathic musculoskeletal pain conditions, such as fibromyalgia and temporomandibular disorder (TMD). 6, 7 In addition to higher pain on mucosal (vestibular) contact, women with VVS show increased pain sensitivity in nongenital sites. 6 A higher prevalence of psychologic traits, such as somatization and anxiety, are also well documented in this population. 6 Collectively, these observations suggest that women with VVS may have an alteration in pain processing pathways. In addition, these women may have psychologic characteristics that facilitate the development of pain. 6, 7 Granot and colleagues 8 were the first to investigate the relationship between alterations in pain processing pathways-as demonstrated by heightened nongenital pain sensitivity-and psychologic traits (such as anxiety) with treatment outcomes. They made an important observation at that subgroups of women with VVS differed in self-reports of anxiety, somatization, and nongenital pain sensitivity. [8] [9] [10] Additionally, in their study, women with higher nongenital pain sensitivity and anxiety tended to respond poorly to conventional treatments for VVS. 8 This work, and that of others, [11] [12] [13] [14] has led to a gradual shift away from the traditional conceptualization of VVS as primarily a mucosal inflammatory process. We hypothesize that VVS is a group of disorders characterized by dysfunctions in the vestibular mucosa (ie, heightened inflammatory response) and central pain processing pathways. However, the extent to which these dysfunctions contribute to the overall clinical picture varies among individuals.
In this study, we explored the overlap between orofacial pain (OFP) and VVS. We embarked on this study after noticing that a high percentage of women with VVS seen in our clinics reported of a distinct pattern of pain in their orofacial regions, which was suggestive of an idiopathic pain condition such as TMD. We also noted that compared with women who had no OFP, those women with OFP were more likely to report pelvic muscle tenderness during gynecologic examination with an inability to relax pelvic muscles.
After consultation with colleagues in OFP research, we used a validated questionnaire to investigate the prevalence of signs/symptoms suggestive of OFP in our cohort of women with VVS. In addition, we investigated the relationship between OFP and self-reported pain during intercourse, and also its association with psychologic characteristics such as anxiety, somatization, and distress.
MATERIALS AND METHODS
This cross-sectional questionnaire study was conducted between February 1, 2003 and October 31, 2005, and was approved by the institutional review board at the University of North Carolina at Chapel Hill. Women diagnosed with VVS during or after January 2002 were eligible for participation. In our clinical practice, the diagnosis of VVS is made by a subjective report of pain during intercourse and tenderness to touch elicited during a cotton swab examination; this diagnosis is only rendered after excluding other identifiable gynecologic disorders. 5 Among participants, the diagnosis of VVS was confirmed by the review of medical records by 2 independent reviewers. Both reviewers were blinded to the participants' responses to the questionnaires. In addition to confirming the diagnosis of VVS, the reviewers assessed eligibility. Disagreements on eligibility (n = 4) were adjudicated by a third reviewer. Women who had VVS with other urogenital pain disorders (eg, vaginismus, generalized vulvodynia, interstitial cystitis), dermatologic conditions (eg, lichen sclerosis), chronic pelvic pain defined as nonmenstrual daily pain localized to the pelvic region, and neuropathies (eg, pudendal neuralgia) were excluded. A total of 196 women were eligible for participation and received both the consent forms and questionnaires. Participants were instructed by a cover letter in the study package to return the completed questionnaires and consent documents in a prestamped envelope. Of the 196 eligible women, 137 (70%) completed the questionnaires and comprise our sample.
The battery of questionnaires included assessments for psychologic characteristics and self-reported pain. Additionally, participants were asked to complete a 9-item, validated questionnaire to assess signs and symptoms suggestive of OFP (eg, TMD). Characteristics of the questionnaire are reviewed below.
Pain Questionnaire
Self-reported pain with intercourse was assessed by administering the Gracely Pain Scale, which asks women to rate the lowest, average, and maximal pain with intercourse on a scale of 0 to 100. 15 Participants are instructed to select verbal descriptors of their pain by circling a word that best describes their pain experience. These verbal descriptors capture 2 important pain domains: (1) sensory (severity of physical pain), and (2) affective (emotional response to a given level of physical pain). A predetermined numerical value for each verbal descriptor was averaged to obtain a summary score for statistical analysis. Modified versions of this questionnaire are commonly used in assessing pain among patients with idiopathic pain disorders (eg, TMD and fibromyalgia).
Psychologic Questionnaires
We administered questionnaires to assess anxiety (Speilberger State-Trait Anxiety Inventory), somatization [Pennebaker Inventory of Limbic Languidness (PILL)], and global psychologic distress [Brief Symptom Inventory (BSI)-Global Severity Index (GSI)]. The following is a brief description of these questionnaires.
The State-Trait Anxiety Inventory (STAI) consists of two 20-item questionnaires, which assess an individual's current anxiety level and general propensity toward anxiety. This instrument has good reliability (retest reliability, r = 73 to 86; Cronbach a = 0.83 to 0.92) and is widely used in clinical research. 16 The norm for a female population of comparable demographics is 36 on both scales. As a comparison, the average score of an inpatient neuropsychiatric population is 47.7 and 46.6, respectively for the state and trait anxiety scales. 16 The Pennebaker Inventory of Limbic Languidness assesses somatization by capturing the frequency of occurrence of 54 common physical symptoms and sensations. It has high internal consistency (a = 0.88) and adequate test-retest reliability (0.70 for a 2-mo period) 17 ; the norm for the female population is 98 to 104. A high baseline somatization score is an independent risk factor for the development of a chronic pain state 7 and is shown to correlate well with the number of tender muscle sites, pain sensitivity, and progression to chronicity. 18 The Brief Symptom Inventory consists of 53 items rating psychologic distress in 9 areas: somatization, obsessive-compulsive, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, and psychoticism. 19 A GSI is obtained by combining the number and intensity of reported symptoms. Internal consistency using Cronbach a ranges from a low of 0.75 (psychoticism) to a high of 0.85 (depression). Test-retest validity for the GSI score is 0.90. 19 The norm for the female population is 50, with a clinical cutoff of 63. 20 Finally, to examine the prevalence of signs and symptoms suggestive of idiopathic pain disorders in the orofacial region, we administered a 9-item, validated screening survey. This survey is commonly used to identify incident cases of TMD, and is validated against the ''gold standard'' physical examination; the sensitivity (100%) and specificity (81%) of this screening survey is high (G. D. Slade, PhD, unpublished data, November, 2005). Participants are queried on the frequency and duration of symptoms such as headache, facial and jaw pain, grinding, and clenching. Two independent reviewers (D.Z. and W.M.) masked to the participants' identification and responses to psychometric questionnaires classified women into the following 3 categories: OFP, subclinical OFP, or no OFP. We classified women as having OFP if they had been previously been diagnosed with TMD or endorsed greater than 3 episodes of headache or ''sinus pain'' per week, and experienced both provoked and spontaneous OFP. We classified women as having subclinical OFP if they denied spontaneous OFP but endorsed provoked OFP, and reported greater than 3 episodes of headache or sinus pain per week. In addition, to be classified in the subclinical OFP category, participants had to report use of night guard, grinding, or clenching. The agreement between the 2 reviewers was high [weighted k = 0.81, 95% confidence interval (0.71, 0.90)]. OFP was defined using 3 categories instead of 2 (OFP vs. not) due to our a priori hypothesis that a large proportion of patients would not fit into either dichotomous category. This hypothesis was based on our previous clinical experience and a common belief among most pain experts that patients with these conditions represent a spectrum of disease rather than a dichotomy.
Data Analysis
Statistical analysis was performed using SAS software (version 9.1; SAS Institute Inc, Cary, NC). We performed bivariate analyses using 1-way analysis of variance or Fisher exact tests to determine if there were differences in patient characteristics among the groups classified by OFP (OFP, subclinical OFP, and no OFP). These characteristics include age, race, education, parity, marital status, duration of pain, and number of prior physicians seen for similar symptoms. Differences in mean intercourse-related pain (Gracely Pain Severity Scale) and psychometric assessments were compared for all groups using the analysis of variance test. All tests comparing the 3 groups were conducted at a = 0.05. If overall differences were detected (P<0.05), Bonferroni procedures were used to adjust the P values, resulting from multiple pair wise comparisons tests (P value Bon,adj ).
RESULTS
Seventy-eight percent (n = 107) of the participants had signs and symptoms suggestive of idiopathic pain conditions in the orofacial region (eg, TMD). Of those, 31% (n = 43) were classified as having subclinical OFP and 47% (n = 64) were classified as having OFP. Demographic characteristics among these subgroups did not differ (Table 1 ). In general, participants were highly educated, young, white women with an average duration of 5 years of painful intercourse. We did not observe any differences with respect to the duration and severity of (Table 1) . However, we observed significant and robust differences in the psychologic characteristics among the 3 subgroups (Table 2 ). Among our cohort of women with VVS, those with OFP had significantly higher levels of anxiety (STAI), somatization (PILL), and global psychologic distress (BSI-GSI) as compared with those without OFP ( Table 2) .
Women with OFP had the highest scores on all measured psychometric indices, whereas those without OFP had the lowest. Women with subclinical OFP, however, consistently fell within these 2 limits. For example, while women with subclinical OFP were similar to those without OFP with respect to psychologic distress (BSI-GSI), they differed significantly on somatization (PILL, Table 2 ). The highest mean score on somatization was seen among women with OFP (125.2, 2 SD above norm), followed by women with subclinical OFP (111, 1 SD above norm). Women without OFP had mean score lower than average for the general population (103.3) ( Table 2) .
DISCUSSION
In our cohort, approximately 8 out of 10 women with VVS had chronic OFP. The most common and widely studied form of chronic OFP-TMD-affects 7% to 15% of the adult population; 80% of the treated cases are women in their early to mid-adulthood. 21 At the present, we cannot irrefutably make a statement about the prevalence of a specific category of OFP. However, on formal evaluation by an OFP specialist (as part of an ongoing follow up study), the majority of our participants have signs and symptoms of TMD.
It is intuitively perplexing as to why an idiopathic OFP disorder (affecting 10% of the general population) 22 is highly prevalent among women with idiopathic genital pain. Another related question that comes to mind is the mechanism by which the distribution of signs and symptoms of OFP mirror the spectrum of psychologic characteristics among women with VVS. Women with VVS and symptoms of OFP had higher levels of anxiety, somatization, and psychologic distress; duration and severity of self-reported pain with intercourse did not differ among categories of OFP.
The association between psychologic traits and OFP among women with VVS may, in part, be explained by specific genetic variants, which mediate the activities of central pain regulatory pathways. For example, polymorphism of the gene encoding catechol-o-methyltransferase is a potent and independent risk factor for the development of chronic pain conditions, such as TMD. 23 Furthermore, the associations between the haplotype variations for the b2 adrenergic receptor and psychologic traits, such as anxiety and somatization, have been identified. 24 We hypothesize that subgroups of women with VVS may share the same genetic vulnerability as women with TMD. 7 Thus, the associations between certain psychologic traits and signs/symptoms of OFP among women with VVS suggest that an inherent susceptibility may permit or even precede the development of VVS in certain women. We therefore speculate that women with VVS are a heterogeneous population and that the observed clinical phenotype is composed of several interactive biologic and psychologic factors.
On the basis of our findings and an emerging body of evidence, we hypothesize that the experience of pain with attempted intercourse may be governed by 2 interdependent processes: (1) a biologic impairment in pain regulatory mechanisms (similar to what is seen among women with TMD and other idiopathic pain conditions), and (2) a genetic predisposition to a heightened inflammatory response in vulvar mucosa. Mucosal sensitivity, though a necessary component of the clinical manifestation of VVS, may not be sufficient for the development of this disorder in all women. Experience of pain, although clinically similar, could in fact be primarily driven by different pathophysiologic *Population norm derived from the participations of a 3-y prospective study on incidence of temporomandibular disorder, the most common form of OFP; the scores are based on participants who did not develop OFP over the study period.
wSTAI-S, Spielberger State Anxiety Inventory describing situational or state related anxiety. zSTAI-T, Spielberger Trait Anxiety Inventory describing general propensity (trait) toward anxiety. yBSI-GSI, composite score for psychologic distress with individual subscale scores.
processes, some that are centrally mediated (ie, biochemical abnormality in pain processing) and some that are peripherally mediated (ie, biochemical abnormality in the inflammatory cascade in the mucosa). Although these results are intriguing, it is important to note that our population reflects the severe end of the spectrum of patients with VVS seen in a referral-based university clinic. The findings from our patient population may not be generalizable to VVS patients seen in primary care. Furthermore, the 137 women who completed the questionnaires that allowed classification of OFP status may differ in important ways from those not reached or not willing to participate in research. It is difficult to hypothesize the direction of bias owing to nonresponse. However, it is unlikely that women who opted against participation or could not be contacted would change our findings because the classification of these women would likely fall equally among the 3 subgroups. Finally, we did not use the gold standard 22 clinical examination for diagnosis of OFP but instead used a validated questionnaire used to identify TMD, the most common form of OFP. This may have resulted in a higher prevalence of OFP. However, the differences across groups with respect to psychosocial variables are in agreement with previous research in TMD 25 and support the likelihood that our categories based on questionnaire responses adequately classified OFP groups.
This study is cross-sectional and therefore temporal sequence cannot be established. Specific psychologic traits may precede or be modified by chronic pain disorders. 6 Psychologic traits may be consequences of living with chronic pain; more importantly, however, such traits may precede the development of chronic pain and be amplified with disease progression.
Research in chronic pain disciplines (eg, OFP, fibromyalgia) requires conceptual models that examine the interplay between psychologic and biologic factors and their ultimate effect on pain pathophysiology. This model is lacking in VVS. Our findings provide additional evidence in support of VVS being an idiopathic pain disorder akin to fibromyalgia and TMD. To that end, we must (1) objectively measure the clinical presentation of VVS as it relates to the vulvar mucosa, pelvic floor muscles, psychologic traits, and central pain processing mechanisms; (2) investigate the potential for distinctive subtypes of VVS; and (3) develop a conceptual framework, incorporating these measures, to guide research in the pathophysiology and treatment of VVS.
